Kamada Ltd.
KMDA · NASDAQ
Bulios Fair Price
$12.16
40.3% upside
Current Price
$8.67
According to Bulios Fair Price, KMDA is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Kamada Ltd. (KMDA) is a biopharmaceutical company engaged in research, development, and manufacturing of therapeutic products. The company specializes in the development and production of protein therapeutics and immunoglobulins for various therapeutic applications. Kamada has developed a range of biological therapeutics and products aimed at treating rare and genetic diseases, including immune deficiencies and hematological disorders. With its innovative products and meticulous research, the company maintains a significant position in the biopharmaceutical sector. Kamada Ltd. (KMDA) also has extensive collaborations with international pharmaceutical companies for the distribution of its therapeutics and the development of new treatment possibilities. Kamada Ltd. (KMDA) shares may be an attractive investment opportunity for investors interested in the biopharmaceutical sector and seeking an investment in a company with an innovative portfolio of therapeutics and potential for further growth in treatment technologies.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Amir London
Employees
462
Headquarters
Rehovot
Upcoming events
Earnings
Upcoming earnings report